4//SEC Filing
Pierce Christopher 4
Accession 0001209191-21-047839
CIK 0001678660other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 6:11 PM ET
Size
5.6 KB
Accession
0001209191-21-047839
Insider Transaction Report
Form 4
Pierce Christopher
EVP and Chief of Business Oper
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-07-20+85,000→ 85,000 totalExercise: $31.23Exp: 2031-07-19→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on July 20, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001824631
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 6:11 PM ET
- Size
- 5.6 KB